Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurodegenerative Changes in Alzheimer's Disease: Effects of Victoza on degenerative changes
2011-000794-31Phase 2Completed
- Sponsor
- Dept. of Pharmacology
- Start
- Jun 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of liraglutide in Alzheimer's disease (AD), sponsored by Dept. of Pharmacology. Primary endpoint: Intracerebral amyloid deposition by Pittsburgh Compound B PET. Started Jun 2011; status: completed.
02
Drugs
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2011-000794-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000794-31.